BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 11:43:00 AM | Browse: 1184 | Download: 946
 |
Received |
|
2013-11-30 12:32 |
 |
Peer-Review Started |
|
2013-11-30 13:42 |
 |
To Make the First Decision |
|
2014-01-15 19:13 |
 |
Return for Revision |
|
2014-01-20 22:26 |
 |
Revised |
|
|
 |
Second Decision |
|
2014-04-09 09:16 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-04-09 09:39 |
 |
Articles in Press |
|
2014-05-23 09:49 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-06-12 18:54 |
 |
Publish the Manuscript Online |
|
2014-07-03 15:30 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Portopulmonary hypertension and hepatopulmonary syndrome
|
Manuscript Source |
Invited Manuscript |
All Author List |
Florence Aldenkortt, Marc Aldenkortt, Laurence Caviezel, Jean Luc Waeber, Anne Weber and Eduardo Schiffer |
Funding Agency and Grant Number |
|
Corresponding Author |
Florence Aldenkortt, MD, Staff Anesthesiologist, Division of Anesthesiology, Department of Anesthesiology, Clinical Pharmacology and Intensive Care, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva, Switzerland. florence.aldenkortt@hcuge.ch |
Key Words |
End stage liver disease; Hepatopulmonary syndrome; Portopulmonary Hypertension; Anesthesia |
Core Tip |
Portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) are frequent complications of liver disease. Both conditions result from diminished hepatic clearance of splanchnic vasoactive substances. They cause pulmonary vasoconstriction in POPH resulting in elevated pulmonary pressure, right ventricular dysfunction and intrapulmonary shunts with hypoxemia in HPS. The only lasting treatment is liver transplantation (LT). Whereas LT results in the disappearance of HPS, its effect on POPH is unpredictable. The anesthesiologist plays a central role in managing HPS and POPH during LT as preoperative screening and grading of the disease allows the selection of appropriate therapies. |
Publish Date |
2014-07-03 15:30 |
Citation |
Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol 2014; 20(25): 8072-8081 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i25/8072.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i25.8072 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345